← Back to Search

Cash Incentives for Type 2 Diabetes (DMCT Trial)

N/A
Recruiting
Led By Jennifer A Campbell, PhD
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit
Age ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline self-care at 6 months post intervention follow-ups
Awards & highlights

DMCT Trial Summary

This trial will test a diabetes intervention (DM-CCT) to see if it is better than the standard of care (UCT) in 100 African Americans with poorly controlled diabetes. The study will look at measures of glycemic control, quality of life, self-care behaviors, and psychological health.

Who is the study for?
This trial is for African Americans living in inner city areas, aged 18 or older, with poorly controlled Type 2 Diabetes (HbA1c ≥8%), and earning around the federal poverty level. They must speak English and not be involved in other diabetes trials, have a life expectancy of at least six months, and no drug abuse issues or severe mental health conditions.Check my eligibility
What is being tested?
The study compares two approaches: DM-CCT involves biweekly virtual education on diabetes management plus stress coping skills tied to cash rewards; DM-UCT provides unconditional cash without these requirements. The goal is to see which method better improves blood sugar control, self-care behaviors, quality of life, and psychological health.See study design
What are the potential side effects?
Since this trial does not involve medication but rather behavioral interventions like education sessions and financial incentives, there are no direct medical side effects. However, participants may experience stress or disappointment if they do not meet the conditions for receiving the cash transfer.

DMCT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have type 2 diabetes with an HbA1c level of 8% or higher.
Select...
I am 18 years old or older.

DMCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline hba1c at 6 months post intervention follow-ups
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline hba1c at 6 months post intervention follow-ups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycemic control (HbA1c)
Quality of Life as measured by SF-12
Secondary outcome measures
Self-Care

DMCT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Diabetes-Tailored CCTs (DM-CCT) InterventionExperimental Treatment1 Intervention
Participants randomized to DM-CCT will receive cash transfers of $500 per month for 6 months, but the cash transfers will be conditional on attending a 60-minute diabetes education/skills training (30 minutes) and stress/coping (30 minutes) session delivered by trained nurses every 2 weeks for 6 months (12 sessions). Therefore, they will only receive cash transfer payments if they attend two sessions per month.
Group II: Unconditional Cash Transfer-UCTs InterventionActive Control1 Intervention
Participants randomized to UCT will receive cash transfers of $500 per month for 6 months, but there will be no conditions attached. Therefore, they will receive cash transfer payments every month. However, to control for content and attention, participants will receive mailed version of the diabetes education/skills training materials every two weeks on the same schedule as the DM-CCT telephone sessions.

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
608 Previous Clinical Trials
1,162,411 Total Patients Enrolled
Jennifer A Campbell, PhDPrincipal InvestigatorMedical College of Wisconsin

Media Library

DM-CCT Clinical Trial Eligibility Overview. Trial Name: NCT05559892 — N/A
Type 2 Diabetes Research Study Groups: Diabetes-Tailored CCTs (DM-CCT) Intervention, Unconditional Cash Transfer-UCTs Intervention
Type 2 Diabetes Clinical Trial 2023: DM-CCT Highlights & Side Effects. Trial Name: NCT05559892 — N/A
DM-CCT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05559892 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies still available for prospective participants in this clinical experiment?

"Affirmative. Clinicaltrials.gov's records indicate that this clinical trial, which was established on November 1st 2022, is actively recruiting participants. The investigation requires 100 people to join from one medical centre."

Answered by AI

What is the volume of participants involved in this clinical research?

"Affirmative. According to clinicaltrials.gov, this research endeavour is still recruiting patients since its initiation on November 1st 2022 and most recent update in October 5th of the same year. This trial requires 100 participants at a single site for completion."

Answered by AI
~67 spots leftby Nov 2026